- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01919697
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
An Open-Label Extension (OLE), Long-term Safety and Tolerability Study of Plecanatide in Patients With Chronic Idiopathic Constipation (CIC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an open-label extension study of plecanatide in the treatment of patients with CIC who previously completed Synergy Protocols SP304-20210 and SP304203-00 (The CIC3 Study).
The planned duration of each patient's study participation is up to 411 days, including up to 33 days of screening, 8 study visits over 52 weeks of treatment and a follow-up visit 2 weeks after the last dose of study drug.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 1Z9
- Synergy Research Site
-
-
Nova Scotia
-
Bridgewater, Nova Scotia, Canada, B4V 3N2
- Synergy Research Site
-
-
Ontario
-
Cambridge, Ontario, Canada, N1S 2M6
- Synergy Research Site
-
Sudbury, Ontario, Canada, P3A 1Y8
- Synergy Research Site
-
Toronto, Ontario, Canada, M3J 2C5
- Synergy Research Site
-
Toronto, Ontario, Canada, M9W 4L6
- Synergy Research Site
-
-
Quebec
-
Mirabel, Quebec, Canada, J7J 2K8
- Synergy Research Site
-
Pointe-Claire, Quebec, Canada, H9R 4S3
- Synergy Research Site
-
St-Romuald, Quebec, Canada, G6W 5M6
- Synergy Research Site
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35242
- Synergy Research Site
-
Dothan, Alabama, United States, 36305
- Synergy Research Site
-
Gulf Shores, Alabama, United States, 36542
- Synergy Research Site
-
Huntsville, Alabama, United States, 35801
- Synergy Research Site
-
-
Arizona
-
Chandler, Arizona, United States, 85224
- Synergy Research Site
-
Phoenix, Arizona, United States, 85018
- Synergy Research Site
-
Tempe, Arizona, United States, 85283
- Synergy Research Site
-
Tucson, Arizona, United States, 85704
- Synergy Research Site
-
Tucson, Arizona, United States, 85712
- Synergy Research Site
-
Tucson, Arizona, United States, 85716
- Synergy Research Site
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72211
- Synergy Research Site
-
North Little Rock, Arkansas, United States, 72117
- Synergy Research Site
-
-
California
-
Anaheim, California, United States, 92801
- Synergy Research Site
-
Anaheim, California, United States, 92804
- Synergy Research Site
-
Artesia, California, United States, 90701
- Synergy Research Site
-
Carlsbad, California, United States, 92008
- Synergy Research Site
-
Cerritos, California, United States, 90703
- Synergy Research Site
-
Chula Vista, California, United States, 91910
- Synergy Research Site
-
Corona, California, United States, 92879
- Synergy Research Site
-
Encinitas, California, United States, 92024
- Synergy Research Site
-
Fountain Valley, California, United States, 92708
- Synergy Research Site
-
Fresno, California, United States, 93726
- Synergy Research Site
-
Hawaiian Gardens, California, United States, 90716
- Synergy Research Site
-
La Mirada, California, United States, 90638
- Synergy Research Site
-
Laguna Hills, California, United States, 92653
- Synergy Research Site
-
Lancaster, California, United States, 93534
- Synergy Research Site
-
Long Beach, California, United States, 90806
- Synergy Research Site
-
Los Angeles, California, United States, 90045
- Synergy Research Site
-
Los Angeles, California, United States, 90015
- Synergy Research Site
-
Mission Hills, California, United States, 91345
- Synergy Research Site
-
North Hollywood, California, United States, 91606
- Synergy Research Site
-
Orange, California, United States, 92868
- Synergy Research Site
-
Pasadena, California, United States, 91105
- Synergy Research Site
-
Sacramento, California, United States, 95821
- Synergy Research Site
-
San Diego, California, United States, 92103
- Synergy Research Site
-
San Diego, California, United States, 92108
- Synergy Research Site
-
San Diego, California, United States, 92114
- Synergy Research Site
-
Thousand Oaks, California, United States, 91360
- Synergy Research Site
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80904
- Synergy Research Site
-
Colorado Springs, Colorado, United States, 80907
- Synergy Research Site
-
Colorado Springs, Colorado, United States, 80909
- Synergy Research Site
-
Denver, Colorado, United States, 80246
- Synergy Research Site
-
Denver, Colorado, United States, 80218
- Synergy Research Site
-
Denver, Colorado, United States, 80220
- Synergy Research Site
-
Littleton, Colorado, United States, 80128
- Synergy Research Site
-
-
Connecticut
-
Bristol, Connecticut, United States, 06010
- Synergy Research Site
-
Waterbury, Connecticut, United States, 06708
- Synergy Research Site
-
-
Florida
-
Boynton Beach, Florida, United States, 33426
- Synergy Research Site
-
Brandon, Florida, United States, 33511
- Synergy Research Site
-
Clearwater, Florida, United States, 33756
- Synergy Research Site
-
Clearwater, Florida, United States, 33759
- Synergy Research Site
-
Cutler Bay, Florida, United States, 33189
- Synergy Research Site
-
DeLand, Florida, United States, 32720
- Synergy Research Site
-
Fort Lauderdale, Florida, United States, 33306
- Synergy Research Site
-
Hialeah, Florida, United States, 33012
- Synergy Research Site
-
Hialeah, Florida, United States, 33013
- Synergy Research Site
-
Hialeah, Florida, United States, 33016
- Synergy Research Site
-
Homestead, Florida, United States, 33030
- Synergy Research Site
-
Jupiter, Florida, United States, 33458
- Synergy Research Site
-
Lakeland, Florida, United States, 33805
- Synergy Research Site
-
Miami, Florida, United States, 33015
- Synergy Research Site
-
Miami, Florida, United States, 33032
- Synergy Research Site
-
Miami, Florida, United States, 33122
- Synergy Research Site
-
Miami, Florida, United States, 33125
- Synergy Research Site
-
Miami, Florida, United States, 33126
- Synergy Research Site
-
Miami, Florida, United States, 33142
- Synergy Research Site
-
Miami, Florida, United States, 33144
- Synergy Research Site
-
Miami, Florida, United States, 33155
- Synergy Research Site
-
Miami, Florida, United States, 33165
- Synergy Research Site
-
Miami, Florida, United States, 33173
- Synergy Research Site
-
Miami, Florida, United States, 33175
- Synergy Research Site
-
Miami, Florida, United States, 33176
- Synergy Research Site
-
Miami, Florida, United States, 33130
- Synergy Research Site
-
Miami, Florida, United States, 33174
- Synergy Research Site
-
Miami, Florida, United States, 33186
- Synergy Research Site
-
Miami Lakes, Florida, United States, 33016
- Synergy Research Site
-
Miami Springs, Florida, United States, 33166
- Synergy Research Site
-
Orlando, Florida, United States, 32806
- Synergy Research Site
-
Orlando, Florida, United States, 32807
- Synergy Research Site
-
Orlando, Florida, United States, 32801
- Synergy Research Site
-
Pembroke Pines, Florida, United States, 33026
- Synergy Research Site
-
Port Orange, Florida, United States, 32129
- Synergy Research Site
-
Saint Petersburg, Florida, United States, 33709
- Synergy Research Site
-
Tamarac, Florida, United States, 33319
- Synergy Research Site
-
Tampa, Florida, United States, 33607
- Synergy Research Site
-
Tampa, Florida, United States, 33606
- Synergy Research Site
-
West Palm Beach, Florida, United States, 33409
- Synergy Research Site
-
-
Georgia
-
Athens, Georgia, United States, 30606
- Synergy Research Site
-
Atlanta, Georgia, United States, 30342
- Synergy Research Site
-
Decatur, Georgia, United States, 30033
- Synergy Research Site
-
Decatur, Georgia, United States, 30032
- Synergy Research Site
-
Oakwood, Georgia, United States, 30566
- Synergy Research Site
-
Sandy Springs, Georgia, United States, 30328
- Synergy Research Site
-
Savannah, Georgia, United States, 31406
- Synergy Research Site
-
Smyrna, Georgia, United States, 30082
- Synergy Research Site
-
Snellville, Georgia, United States, 30078
- Synergy Research Site
-
-
Idaho
-
Blackfoot, Idaho, United States, 83221
- Synergy Research Site
-
-
Illinois
-
Chicago, Illinois, United States, 60602
- Synergy Research Site
-
-
Indiana
-
Brownsburg, Indiana, United States, 46112
- Synergy Research Site
-
-
Iowa
-
Clive, Iowa, United States, 50325
- Synergy Research Site
-
-
Kansas
-
Augusta, Kansas, United States, 67010
- Synergy Research Site
-
Newton, Kansas, United States, 67114
- Synergy Research Site
-
Shawnee Mission, Kansas, United States, 66218
- Synergy Research Site
-
Wichita, Kansas, United States, 67205
- Synergy Research Site
-
Wichita, Kansas, United States, 67207
- Synergy Research Site
-
-
Kentucky
-
Lexington, Kentucky, United States, 40503
- Synergy Research Site
-
Owensboro, Kentucky, United States, 42303
- Synergy Research Site
-
-
Louisiana
-
Bastrop, Louisiana, United States, 71220
- Synergy Research Site
-
Marrero, Louisiana, United States, 70072
- Synergy Research Site
-
Metairie, Louisiana, United States, 70006
- Synergy Research Site
-
New Orleans, Louisiana, United States, 70115
- Synergy Research Site
-
New Orleans, Louisiana, United States, 70119
- Synergy Research Site
-
Shreveport, Louisiana, United States, 71103
- Synergy Research Site
-
-
Maryland
-
Chevy Chase, Maryland, United States, 20815
- Synergy Research Site
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02131
- Synergy Research Site
-
New Bedford, Massachusetts, United States, 02740
- Synergy Research Site
-
-
Michigan
-
Chesterfield, Michigan, United States, 48047
- Synergy Research Site
-
Flint, Michigan, United States, 48504
- Synergy Research Site
-
Rochester, Michigan, United States, 48307
- Synergy Research Site
-
Saginaw, Michigan, United States, 48604
- Synergy Research Site
-
Southfield, Michigan, United States, 48034
- Synergy Research Site
-
-
Mississippi
-
Biloxi, Mississippi, United States, 39531
- Synergy Research Site
-
Jackson, Mississippi, United States, 39202
- Synergy Research Site
-
-
Missouri
-
Saint Louis, Missouri, United States, 63128
- Synergy Research Site
-
-
Nebraska
-
Grand Island, Nebraska, United States, 68803
- Synergy Research Site
-
Omaha, Nebraska, United States, 68114
- Synergy Research Site
-
-
Nevada
-
Henderson, Nevada, United States, 89014
- Synergy Research Site
-
Las Vegas, Nevada, United States, 89103
- Synergy Research Site
-
Las Vegas, Nevada, United States, 89119
- Synergy Research Site
-
Las Vegas, Nevada, United States, 89121
- Synergy Research Site
-
Reno, Nevada, United States, 89511
- Synergy Research Site
-
-
New Jersey
-
Elizabeth, New Jersey, United States, 07202
- Synergy Research Site
-
Lodi, New Jersey, United States, 07644
- Synergy Research Site
-
Marlton, New Jersey, United States, 08053
- Synergy Research Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87109
- Synergy Research Site
-
Albuquerque, New Mexico, United States, 87108
- Synergy Research Site
-
-
New York
-
Brooklyn, New York, United States, 11206
- Synergy Research Site
-
Great Neck, New York, United States, 11023
- Synergy Research Site
-
New York, New York, United States, 10016
- Synergy Research Site
-
Poughkeepsie, New York, United States, 12601
- Synergy Research Site
-
-
North Carolina
-
Cary, North Carolina, United States, 27518
- Synergy Research Site
-
Chapel Hill, North Carolina, United States, 27599
- Synergy Research Site
-
Charlotte, North Carolina, United States, 28210
- Synergy Research Site
-
Charlotte, North Carolina, United States, 28277
- Synergy Research Site
-
Greensboro, North Carolina, United States, 27403
- Synergy Research Site
-
Kinston, North Carolina, United States, 28501
- Synergy Research Site
-
Raleigh, North Carolina, United States, 27612
- Synergy Research Site
-
Wilmington, North Carolina, United States, 28401
- Synergy Research Site
-
Winston-Salem, North Carolina, United States, 27103
- Synergy Research Site
-
-
North Dakota
-
Fargo, North Dakota, United States, 58103
- Synergy Research Site
-
-
Ohio
-
Beavercreek, Ohio, United States, 45432
- Synergy Research Site
-
Centerville, Ohio, United States, 45459
- Synergy Research Site
-
Cincinnati, Ohio, United States, 45224
- Synergy Research Site
-
Cincinnati, Ohio, United States, 45246
- Synergy Research Site
-
Cleveland, Ohio, United States, 44122
- Synergy Research Site
-
Huber Heights, Ohio, United States, 45424
- Synergy Research Site
-
Maumee, Ohio, United States, 43537
- Synergy Research Site
-
Mentor, Ohio, United States, 44060
- Synergy Research Site
-
Oakwood, Ohio, United States, 45419
- Synergy Research Site
-
Stow, Ohio, United States, 44224
- Synergy Research Site
-
-
Oklahoma
-
Norman, Oklahoma, United States, 73071
- Synergy Research Site
-
Oklahoma City, Oklahoma, United States, 73104
- Synergy Research Site
-
Oklahoma City, Oklahoma, United States, 73102
- Synergy Research Site
-
-
Pennsylvania
-
Levittown, Pennsylvania, United States, 19056
- Synergy Research Site
-
Limerick, Pennsylvania, United States, 19468
- Synergy Research Site
-
Philadelphia, Pennsylvania, United States, 19152
- Synergy Research Site
-
Pittsburgh, Pennsylvania, United States, 15206
- Synergy Research Site
-
Yardley, Pennsylvania, United States, 19067
- Synergy Research Site
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- Synergy Research Site
-
Charleston, South Carolina, United States, 29406
- Synergy Research Site
-
Columbia, South Carolina, United States, 29203
- Synergy Research Site
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37421
- Synergy Research Site
-
Franklin, Tennessee, United States, 37064
- Synergy Research Site
-
Jackson, Tennessee, United States, 38305
- Synergy Research Site
-
Knoxville, Tennessee, United States, 37912
- Synergy Research Site
-
Memphis, Tennessee, United States, 38119
- Synergy Research Site
-
Nashville, Tennessee, United States, 37211
- Synergy Research Site
-
New Tazewell, Tennessee, United States, 37825
- Synergy Research Site
-
-
Texas
-
Arlington, Texas, United States, 76012
- Synergy Research Site
-
Austin, Texas, United States, 78731
- Synergy Research Site
-
Austin, Texas, United States, 78745
- Synergy Research Site
-
Channelview, Texas, United States, 77530
- Synergy Research Site
-
Dallas, Texas, United States, 75230
- Synergy Research Site
-
Dallas, Texas, United States, 75234
- Synergy Research Site
-
Houston, Texas, United States, 77062
- Synergy Research Site
-
Houston, Texas, United States, 77034
- Synergy Research Site
-
Houston, Texas, United States, 77043
- Synergy Research Site
-
Houston, Texas, United States, 77070
- Synergy Research Site
-
Houston, Texas, United States, 77090
- Synergy Research Site
-
Houston, Texas, United States, 77099
- Synergy Research Site
-
Humble, Texas, United States, 77338
- Synergy Research Site
-
Katy, Texas, United States, 77450
- Synergy Research Site
-
Plano, Texas, United States, 75093
- Synergy Research Site
-
San Antonio, Texas, United States, 78215
- Synergy Research Site
-
San Antonio, Texas, United States, 78209
- Synergy Research Site
-
Sugar Land, Texas, United States, 77479
- Synergy Research Site
-
-
Utah
-
Logan, Utah, United States, 84341
- Synergy Research Site
-
Saint George, Utah, United States, 84790
- Synergy Research Site
-
Salt Lake City, Utah, United States, 84124
- Synergy Research Site
-
West Jordan, Utah, United States, 84088
- Synergy Research Site
-
-
Virginia
-
Christiansburg, Virginia, United States, 24073
- Synergy Research Site
-
Henrico, Virginia, United States, 23233
- Synergy Research Site
-
Lynchburg, Virginia, United States, 24502
- Synergy Research Site
-
Newport News, Virginia, United States, 23606
- Synergy Research Site
-
Norfolk, Virginia, United States, 23507
- Synergy Research Site
-
Norfolk, Virginia, United States, 23502
- Synergy Research Site
-
Richmond, Virginia, United States, 23294
- Synergy Research Site
-
-
Washington
-
Richland, Washington, United States, 99352
- Synergy Research Site
-
Seattle, Washington, United States, 98105
- Synergy Research Site
-
Tacoma, Washington, United States, 98405
- Synergy Research Site
-
-
Wisconsin
-
Wauwatosa, Wisconsin, United States, 53226
- Synergy Research Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient completed a previous double-blind plecanatide study and was compliant with the study requirements.
- Patient is in good health without unstable acute illness or exacerbation of an unstable chronic illness or chronic disease that may affect study assessments, particularly if there has been a significant change to health status since the previous plecanatide study.
Exclusion Criteria:
- Patient has had major surgery including laparoscopic procedures requiring general anesthesia within 60 days of Day 1.
- Patient has a medical history of hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
- Patient has taken a protocol-prohibited drug without the appropriate washout period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Plecanatide 3.0 mg
Plecanatide 3.0 mg, one tablet by mouth daily for 52 weeks
|
|
Experimental: Plecanatide 6.0 mg
Plecanatide 6.0 mg, one tablet by mouth daily for 52 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE)
Time Frame: From first dose up to 72 weeks
|
All clinically significant findings upon Physical Examinations of the Safety Population during the treatment period were reported as TEAEs.
Safety was evaluated based on number of patients who experienced at least one TEAE.
|
From first dose up to 72 weeks
|
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE) Leading to Discontinuation of Plecanatide
Time Frame: From first dose up to 72 weeks
|
Tolerability was evaluated based on number of patients who experienced at least one TEAE leading to discontinuation of the study drug
|
From first dose up to 72 weeks
|
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)
Time Frame: From first dose up to 72 weeks
|
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
|
From first dose up to 72 weeks
|
Summary of Vital Signs at >Day 364 - Heart Rate (Beats Per Minute)
Time Frame: From first dose up to 72 weeks
|
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
|
From first dose up to 72 weeks
|
Summary of Vital Signs at >Day 364 - Body Temperature (°C)
Time Frame: From first dose up to 72 weeks
|
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
|
From first dose up to 72 weeks
|
Summary of Vital Signs at >Day 364 - Respiration Rate (Breaths Per Minute)
Time Frame: From first dose up to 72 weeks
|
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
|
From first dose up to 72 weeks
|
Summary of ECG Results Shift From Baseline at > Day 364
Time Frame: From first dose up to 72 weeks
|
Baseline was defined as the last non-missing value collected prior to first dose of study drug)
|
From first dose up to 72 weeks
|
Summary of Treatment-Emergent Laboratory Abnormalities With At Least a 1-grade Shift From Baseline
Time Frame: From first dose up to 72 weeks
|
Baseline was defined as the last non-missing value collected prior to first dose of study drug within a given entry into the study.
The Common Terminology Criteria for Adverse Events (CTCAE), Grades 1 through 5 were used for descriptions of severity for each Adverse Event (AE): Grade 1 - Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated; Grade 2 - Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental Activities of Daily Living (ADL); Grade 3 - Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL; Grade 4 - Life-threatening consequences; urgent intervention indicated; Grade 5 - Death related to AE.
|
From first dose up to 72 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Summary of Patient Patient Global Assessment (PGA) for Constipation Severity at > Day 364
Time Frame: Form first dose up to 72 weeks
|
Constipation severity was measured using a 5-point score: 1=None, 2=Mild, 3=Moderate, 4=Severe, 5=Very severe Baseline was defined as the last non-missing value collected prior to first dose of study drug within a given entry into the study.
|
Form first dose up to 72 weeks
|
Summary of Patient Global Assessment (PGA) for Constipation - Change From Baseline to > Day 364
Time Frame: From first dose up to 72 weeks
|
Change of Constipation measured using a 7-point score: 1=Very Much Improved, 2=Much Improved, 3=Minimally Improved, 4=No change, 5=Minimally Worse, 6=Much Worse, 7=Very Much Worse Baseline is defined as the last non-missing value collected prior to first dose of study drug within a given entry into the study.
|
From first dose up to 72 weeks
|
Summary of Patient Global Assessment (PGA) for Treatment Satisfaction at > Day 364
Time Frame: From first dose up to 72 weeks
|
Baseline was defined as the last non-missing value collected prior to first dose of study drug within a given entry into the study.
Treatment Satisfaction was measured using a 5-point score: 1=Not At All Satisfied, 2=A Little Satisfied, 3=Moderately Satisfied, 4=Quite Satisfied, 5=Very Satisfied.
|
From first dose up to 72 weeks
|
Summary of Patient Global Assessment (PGA) for Treatment Continuation at End of Treatment
Time Frame: From first dose up to 72 weeks
|
Treatment continuation was measured using 5-point score: 1=Not At All Likely, 2=A Little Likely, 3=Moderately Likely, 4=Quite Likely, 5=Very Likely
|
From first dose up to 72 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Richard A Krause, MD, ClinSearch, LLC
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SP304203-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Idiopathic Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
Vibrant Ltd.CompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States, Canada
-
MallinckrodtTakeda; Sucampo Pharma Americas, LLC; Sucampo AGCompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
TriHealth Inc.Terminated
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria, Netherlands
-
CES UniversityNot yet recruitingConstipation Chronic Idiopathic
Clinical Trials on Plecanatide
-
Bausch Health Americas, Inc.ParexelCompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.Completed
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Active, not recruitingFunctional ConstipationChina
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
Bausch Health Americas, Inc.CompletedChronic Idiopathic ConstipationUnited States, Canada